Loading...
XHKG
8026
Market cap78mUSD
Dec 04, Last price  
0.40HKD
1D
2.56%
1Q
8.11%
Jan 2017
75.44%
IPO
-89.47%
Name

China Brilliant Global Ltd

Chart & Performance

D1W1MN
XHKG:8026 chart
P/E
60.96
P/S
5.72
EPS
0.01
Div Yield, %
Shrs. gr., 5y
0.48%
Rev. gr., 5y
0.29%
Revenues
107m
+17.66%
59,050,00051,222,00083,339,000109,477,00069,141,00085,846,00067,244,00057,161,00024,209,0009,763,00010,050,00030,255,00064,739,00084,047,000105,806,00059,038,00077,806,00093,930,00091,254,000107,372,000
Net income
10m
P
-27,180,000-34,489,00026,487,00015,636,000-6,805,0001,295,000-25,475,000-29,377,000-41,613,000-29,707,000-31,359,000-23,657,00023,329,000-54,006,000-38,111,000-41,052,000-37,322,000-40,784,000-68,926,00010,068,000
CFO
12m
-55.39%
-14,260,000-30,141,0006,577,00050,723,000-11,437,000-39,555,00030,592,000-26,858,000-27,909,000-21,611,000-55,095,000-32,838,000-8,394,000-3,405,000-19,486,000-31,813,000-38,275,000-43,352,00027,422,00012,233,000
Dividend
Nov 30, 20000.025 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China Brilliant Global Limited, an investment holding company, engages in the research and development, design, wholesale, and retail of gold and jewelry, and related ancillary businesses in Hong Kong and the Peoples' Republic of China. The company operates through Gold and Jewellery Business, Lending Business, and Fintech Business segments. It is also involved in the banking activities, such as accepting deposits, granting credits, advising on credit financing, and arranging credit financing, as well as provision of money services; and money lending business. The company was formerly known as Prosten Health Holdings Limited and changed its name to China Brilliant Global Limited in May 2018. China Brilliant Global Limited was incorporated in 1989 and is headquartered in Sheung Wan, Hong Kong. China Brilliant Global Limited is a subsidiary of Brilliant Chapter Limited.
IPO date
Mar 28, 2000
Employees
33
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT